ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65

Nucleic Acids Research

Volumn 43, Issue 3, 2015, Pages 1609-1625

  Kim, Min Young ^a   Koh, Dong In ^a   Choi, Won Il ^a   Jeon, Bu Nam ^a   Jeong, Deok Yoon ^a   Kim, Kyung Sup ^a   Kim, Kunhong ^a   Kim, Se Hoon ^a   Hur, Man Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE; LACTIC ACID; ONCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN ZBTB2; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 4; PYRUVIC ACID; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; PRIMER DNA; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR SP1; ZBTB2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASE PAIRING; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENE INTERACTION; GENE PRODUCT; GENE REPRESSION; GENE TARGETING; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; P65 GENE; PDK4 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RELA GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; ZBTB2 GENE; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALIA;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84936079671     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv026     Document Type: Article

References (46)

1. Kelly,K.F. and Daniel,J.M. (2006) POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol., 16, 578-587.
2. Jeon,B.N., Kim,M.K., Choi,W.I., Koh,D.I., Hong,S.Y., Kim,K.S., Kim,M., Yun,C.O., Yoon,J., Choi,K.Y. et al. (2012) KR-POK interacts with p53 and represses CDKN1A transcription activation by p53. Cancer Res., 72, 1137-1148.
3. Choi,W.I., Jeon,B.N., Park,H., Yoo,J.Y., Kim,Y.S., Koh,D.I., Kim,M.H., Kim,Y.R., Lee,C.E., Kim,K.S. et al. (2008) Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN). J. Biol. Chem., 283, 29341-29354.
4. Jeon,B.N., Yoo,J.Y., Choi,W.I., Lee,C.E., Yoon,H.G. and Hur,M.W. (2008) Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J. Biol. Chem., 283, 33199-33210.
5. Choi,W.I., Jeon,B.N., Yun,C.O., Kim,P.H., Kim,S.E., Choi,K.Y., Kim,S.H. and Hur,M.W. (2009) Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J. Biol. Chem., 284, 12633-12644.
6. Koh,D.I., Choi,W.I., Jeon,B.N., Lee,C.E., Yun,C.O. and Hur,M.W. (2009) A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. J. Biol. Chem., 284, 19856-19866.
7. Jeon,B.N., Choi,W.I., Yu,M.Y., Yoon,A.R., Kim,M.H., Yun,C.O. and Hur,M.W. (2009) ZBTB2, a novel master regulator of the p53 pathway. J. Biol. Chem., 284, 17935-17946.
8. Pardo,M., Lang,B., Yu,L., Prosser,H., Bradley,A., Babu,M.M. and Choudhary,J. (2010) An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell, 6, 382-395.
9. Brass,A.L., Dykxhoorn,D.M., Benita,Y., Yan,N., Engelman,A., Xavier,R.J., Lieberman,J. and Elledge,S.J. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science., 319, 921-926.
10. van Nuland,R., Smits,A.H., Pallaki,P., Jansen,P.W., Vermeulen,M. and Timmers,H.T. (2013) Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Mol. Cell. Biol., 33, 2067-2077.
11. Wang,Y., Zheng,X., Zhang,Z., Zhou,J., Zhao,G., Yang,J., Xia,L., Wang,R., Cai,X., Hu,H. et al. (2012) MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PLoS ONE, 7, e41693.
12. Kim,D.H., Lee,S.T., Won,H.H., Kim,S., Kim,M.J., Kim,H.J., Kim,S.H., Kim,J.W., Kim,H.J., Kim,Y.K. et al. (2011) A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood, 117, 6906-6911.
13. Mu,J.J., Wang,Y., Luo,H., Leng,M., Zhang,J., Yang,T., Besusso,D., Jung,S.Y. and Qin,J. (2007) A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints. J. Biol. Chem., 282, 17330-17334.
14. Jung,S.Y., Malovannaya,A., Wei,J., O'Malley,B.W. and Qin,J. (2005) Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. Mol. Endocrinol., 19, 2451-2465.
15. Gylfe,A.E., Kondelin,J., Turunen,M., Ristolainen,H., Katainen,R., Pitka¨nen,E., Kaasinen,E., Rantanen,V., Tanskanen,T., Varjosalo,M. et al. (2013) Identification of candidate oncogenes in human colorectal cancers with microsatellite instability. Gastroenterology, 145, 540-543.
16. Hayden,M.S., West,A.P. and Ghosh,S. (2006) NF-kappaB and the immune response. Oncogene, 25, 6758-6780.
17. Li,Q. and Verma,I.M. (2002) NF-kappaB regulation in the immune system. Nat. Rev. Immunol., 2, 725-734.
18. Bonizzi,G. and Karin,M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol., 25, 280-288.
19. Wong,H.R., Ryan,M. and Wispé,J.R. (1997) Stress response decreases NF-kappaB nuclear translocation and increases I-kappaBalpha expression in A549 cells. J. Clin. Invest., 99, 2423-2428.
20. Pahl,H.L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853-6866.
21. Hayden,M.S. and Ghosh,S. (2004) Signaling to NF-kappaB. Genes Dev, 18, 2195-2224.
22. Gerondakis,S., Grossmann,M., Nakamura,Y., Pohl,T. and Grumont,R. (1999) Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene, 18, 6888-6895.
23. Karin,M. (2009) NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol., 1, a000141.
24. Tak,P.P. and Firestein,G.S. (2001) NF-κB: a key role in inflammatory diseases. J. Clin. Invest., 107, 7-11.
25. Baker,R.G., Hayden,M.S. and Ghosh,S. (2011) NF-κB, inflammation, and metabolic disease. Cell Metab., 13, 11-22.
26. Hayden,M.S. and Ghosh,S. (2011) NF-κB in immunobiology., Cell Res., 21, 223-244.
27. Zhong,H., Voll,R.E. and Ghosh,S. (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell, 1, 661-671.
28. Rothgiesser,K.M., Valovka,T., Owen,H.R., Rehrauer,H. and Fey,M. (2008) Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65. Nucleic Acids Res., 36, 1665-1680.
29. Ea,C.K. and Baltimore,D. (2009) Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc. Natl. Acad. Sci. U.S.A., 106, 18972-18977.
30. Ueberla,K., Lu,Y., Chung,E. and Haseltine,W.A. (1993) The NF-kappa B p65 promoter. J. Acquir. Immune Defic. Syndr., 6, 227-230.
31. Yurochko,A.D., Kowalik,T.F., Huong,S.M. and Huang,E.S. (1995) Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol., 69, 5391-5400.
32. Yurochko,A.D., Mayo,M.W., Poma,E.E., Baldwin,A.S. Jr and Huang,E.S. (1997) Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J. Virol., 71, 4638-4648.
33. Gu,L., Findley,H.W. and Zhou,M. (2002) MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood, 9, 3367-3375.
34. Sutendra,G. and Michelakis,E.D. (2013) Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front. Oncol., 3, 38.
35. Wende,A.R., Huss,J.M., Schaeffer,P.J., Giguère,V. and Kelly,D.P. (2005) PGC-1α coactivates PDK4 gene expression via the orphan nuclear receptor ERRα: a mechanism for transcriptional control of muscle glucose metabolism. Mol. Cell. Biol., 25, 10684-10694.
36. Alvarez-Guardia,D., Palomer,X., Coll,T., Davidson,M.M., Chan,T.O., Feldman,A.M., Laguna,J.C. and Vázquez-Carrera,M. (2010) The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc. Res., 87, 449-458.
37. Collett,G.P. and Campbell,F.C. (2006) Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis, 27, 1285-1291.
38. Wang,J., Jacob,N.K., Ladner,K.J., Beg,A., Perko,J.D., Tanner,S.M., Liyanarachchi,S., Fishel,R. and Guttridge,D.C. (2009) RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep., 10, 1272-1278.
39. Ashburner,B.P., Westerheide,S.D. and Baldwin,A.S. Jr (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol., 21, 7065-7077.
40. Kurokouchi,K., Kambe,F., Yasukawa,K., Izumi,R., Ishiguro,N., Iwata,H. and Seo,H (1998) TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. J. Bone Miner. Res. 13, 1290-1299.
41. Higai,K., Ishihara,S. and Matsumoto,K. (2006) NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha. Biol. Pharm. Bull. 29, 2372-2377.
42. McFate,T., Mohyeldin,A., Lu,H., Thakar,J., Henriques,J., Halim,N.D., Wu,H., Schell,M.J., Tsang,T.M., Teahan,O. et al. (2008) Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J. Biol. Chem., 283, 22700-22708.
43. Attia,R.R., Sharma,P., Janssen,R.C., Friedman,J.E., Deng,X., Lee,J.S., Elam,M.B., Cook,G.A. and Park,E.A. (2011) Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by CCAAT/enhancer-binding protein beta (C/EBPbeta). J. Biol. Chem., 286, 23799-23807.
44. Piao,L., Sidhu,V.K., Fang,Y.H., Ryan,J.J., Parikh,K.S., Hong,Z., Toth,P.T., Morrow,E., Kutty,S., Lopaschuk,G.D. et al. (2013) FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. J. Mol. Med., 91, 333-346.
45. Vander Heiden,M.G., Locasale,J.W., Swanson,K.D., Sharfi,H., Heffron,G.J., Amador-Noguez,D., Christofk,H.R., Wagner,G., Rabinowitz,J.D., Asara,J.M. et al. (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science, 329, 1492-1499.
46. Lunt,S.Y. and Vander Heiden,M.G. (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol., 27, 441-464.